41 A randomized managed trial illustrated the advance of liver functions and reduction of serious bacterial infections in clients with hepatitis B virus-relevant ACLF receiving allogeneic bone marrow-derived MSCs (BM-MSCs) by means of peripheral infusion.forty two HSCs from peripheral blood following the G-CSF mobilization procedure were used in a